Skip to content

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

News

Choose Year
Search Press Releases

Found 180 Results

November 13, 2025

Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts

October 1, 2025

Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang

September 23, 2025

Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors

July 9, 2025

Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

June 2, 2025

Sernova Appoints Jonathan Rigby as Interim Chair

May 26, 2025

Chair of Sernova Biotherapeutics Resigns

May 22, 2025

Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes

May 14, 2025

Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

April 17, 2025

Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans

April 15, 2025

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

12 3 4 5...10...»

IR Contact

David Burke
Vice President, Investor Relations
917.751.5713
david.burke@sernova.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

PO Box 29592
RPO Central Parkway,
Mississauga, Ontario,
L5A 4H2
info@sernova.com

Company

About Us
Leadership
Board of Directors
Careers
Contact

Science

Our Focus
Type 1 diabetes
Pipeline
Library

Investors

Overview
News
Events
Financial Reports
Stock Information
Corporate Governance

Privacy Policy
Legal Notice

© 2026 Sernova Biotherapeutics. All rights reserved.

Scroll to Top